GHdC Notre Dame

Charleroi 6000

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer — Completed